Regulatory B cells play a key role in immune system balance

Joint Bone Spine

Volumn 80, Issue 1, 2013, Pages 18-22

  Berthelot, Jean Marie ^a   Jamin, Christophe ^b   Amrouche, Kahina ^b   Le Goff, Benoit ^a   Maugars, Yves ^a   Youinou, Pierre ^b  

^a HÔTEL DIEU   (France)

^b UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

Author keywords

Autoimmunity; B lymphocyte; Br1; Br3; Foxp3; IL 10; Regulatory B cells

Indexed keywords

CD24 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLATIRAMER; INTERLEUKIN 10; LYMPHOCYTE ANTIGEN RECEPTOR; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANTIBODY PRODUCTION; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CYTOKINE RELEASE; CYTOTOXICITY; ENTERITIS; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; INTESTINE FLORA; LUPUS ERYTHEMATOSUS; MUCOSA; MULTIPLE SCLEROSIS; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SHORT SURVEY;

ANIMALS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; B-LYMPHOCYTES, REGULATORY; DISEASE MODELS, ANIMAL; HUMANS; HYPERSENSITIVITY; IMMUNE SYSTEM; INTERLEUKIN-10; T-LYMPHOCYTES, REGULATORY;

EID: 84872867376     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2012.04.010     Document Type: Short Survey

References (60)

1. Mauri C., Ehrenstein M.R. The " short" history of regulatory B cells. Trends Immunol 2007, 29:34-40.
2. Noh G., Lee J.H. Regulatory B cells and allergic diseases. Allergy Asthma Immunol Res 2011, 3:168-177.
3. Cunningham-Rundles C. Autoimmunity in immune deficiency: taking lessons from our patients. Clin Exp Immunol 2011, 164:6-11.
4. Youinou P., Mackenzie L., Broker B.M., et al. The importance of CD5-positive B cells in non-organ-specific autoimmune diseases. Scand J Rheumatol Suppl 1988, 76:243-249.
5. Neuwell K.A., Asare A., Kirk A.D., et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010, 120:1836-1847.
6. Jamin C., Morva A., Lemoine S., et al. Regulatory B lymphocytes in humans. A potential role in autoimmunity. Arthritis Rheum 2008, 58:1900-1906.
7. Blair P.A., Noreña L.Y., Flores-Borja F., et al. CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010, 32:129-140.
8. Lemoine S., Morva A., Youinou P., et al. Human T cells induce their own regulation through activation of B cells. J Autoimmun 2011, 36:228-238.
9. Yang M., Sun L., Wang S., et al. Novel function of B cell-activating factor in the induction of IL-10 producing regulatory B cells. J Immunol 2010, 184:3321-3325.
10. Hamaguchi Y. Molecular mechanisms of B lymphocyte depletion by CD20 immunotherapy. Nihon Rinsho Meneki Gakkai Kaishi 2009, 32:29-34.
11. Pers J.O., Daridon C., Bendaoud B., et al. B cell depletion and repopulation in autoimmune diseases. Clin Rev Allergy Immunol 2008, 34:50-55.
12. Klinker M.W., Lundy S.K. Multiple mechanisms of immune suppression by B lymphocytes. Mol Med 2012, 18:123-137.
13. Morlacchi S., Soldani C., Viola A., et al. Self-antigen presentation by mouse B cells results in regulatory T cell induction rather than energy or clonal deletion. Blood 2011, 118:984-991.
14. Shaw P.X., Horkko S., Chang M.K., et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 2000, 105:1731-1740.
15. Yanaba K., Bouaziz J.D., Matsushita T. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 2009, 182:7459-7472.
16. Sindhava V., Woodman M.E., Stevenson B., et al. Interleukin-10 mediated autoregulation of murine B-1 B cells and its role in Borrelia hermsii infection. PLoS One 2010, 5:e11445.
17. Poe J.C., Smith S.H., Haas K.M., et al. Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. PLoS One 2011, 6:e22464.
18. Yanaba K., Bouaziz J.D., Haas K.M., et al. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008, 28:639-650.
19. Matsumoto M., Fujii Y., Baba A., et al. The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production. Immunity 2011, 34:703-714.
20. Maseda D., Smith S.H., Dilillo D.J., et al. Regulatory b10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. J Immunol 2012, 188:1036-1048.
21. Ding Q., Yeung M., Camirand G., et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest 2011, 121:3645-3656.
22. Carnero-Montoro E., Bonet L., Engelken J., et al. Evolutionary and functional evidence for positive selection at the human CD5 immune receptor gene. Mol Biol Evol 2012, 29:811-823.
23. Garaud S., Morva A., Lemoine S., et al. CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation. J Immunol 2011, 186:4835-4844.
24. Díaz-Alderete A., Crispin J.C., Vargas-Rojas M.I., et al. IL-10 production in B cells is confined to CD154+ cells in patients with systemic lupus erythematosus. J Autoimmun 2004, 23:379-383.
25. Lundy S.K. Killer B lymphocytes: the evidence and the potential. Inflamm Res 2009, 10.1007/s00011-009-0014-x.
26. Lee J.H., Noh J., Noh G., et al. IL-10 is predominantly produced by CD19(low)CD5(+) regulatory B cell subpopulation: characterisation of CD19(high) and CD19(low) subpopulations of CD5(+) B cells. Yonsei Med J 2011, 52:851-855.
27. Fujimoto M. Regulatory B cells in skin and connective tissue diseases. J Dermatol Sci 2010, 60:1-7.
28. Garaud S., Le Dantec C., de Mendoza A.R., et al. IL-10 production by B cells expressing CD5 with the alternative exon 1B. Ann N Y Acad Sci 2009, 1173:280-285.
29. Iwata Y., Matsushita T., Horikawa M., et al. Characterization of a rare IL-10-competent B cell subset in humans that parallels mouse regulatory B10 cells. Blood 2011, 117:530-541.
30. Teichmann L.L., Kashgarian M., Weaver C.T., et al. B cell-derived IL-10 does not regulate spontaneous systemic autoimmunity in MRL.Faslpr mice. J Immunol 2012, 188:678-685.
31. Lee J.H., Noh J., Noh G., et al. Allergen-specific transforming growth factor-β-producing CD19+CD5+ regulatory B cell (Br3) responses in human late eczematous allergic reactions to cow's milk. J Interferon Cytokine Res 2011, 31:441-449.
32. Noh J., Choi W.S., Noh S., et al. Presence of Foxp3-expressing CD19(+)CD5(+) B cells in human peripheral blood mononuclear cells: human CD19(+)CD5(+)Foxp3(+) regulatory B cell (Breg). Immune Netw 2010, 10:247-249.
33. Zennaro D., Scala E., Pomponi D., et al. Proteomics plus genomics approaches in primary immunodeficiency: the case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Clin Exp Immunol 2012, 167:120-128.
34. Brisslert M., Bokarewa M., Larsson P., et al. Phenotypic and functional characterization of human CD25+ B cells. Immunology 2006, 117:548-557.
35. Snir A., Kessel A., Haj T., et al. Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy. Clin Exp Rheumatol 2011, 29:697-700.
36. Biton J., Boissier M.C., Bessis N. TNF-alpha: activator or inhibitor of regulatory T cells?. Joint Bone Spine 2012, 79:119-123.
37. Berhelot J.M., Le Goff B., Maugars Y. Thymic Hassall's corpuscles, regulatory T cells, and rheumatoid arthritis. Semin Arthritis Rheum 2010, 39:347-355.
38. Lundy S.K., Fox D.A. Reduced Fas-ligand expressing splenic CD5+ lymphocytes in severe collagen-induced arthritis. Arthritis Res Ther 2009, 11:R-128.
39. Lo-Man R. Regulatory B cells control dendritic cell functions. Immunotherapy 2011, 3:19-20.
40. Morva A., Lemoine S., Achour A., et al. Maturation and function of human dendritic cells are regulated by B lymphocytes. Blood 2012, 119:106-114.
41. Reichardt P., Dornbach B., Rong S., et al. Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse. Blood 2007, 110:1519-1529.
42. Wei B., Velazquez P., Turovskaya O., et al. cells centrally inhibit CD4+T cell colitis through interaction with regulatory T cell subsets. Proc Natl Acad Sci U S A 2005, 102:2010-2015.
43. Carter N.A., Vasconcellos R., Rosser E.C., et al. Mice lacking endogenous IL-10 producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol 2011, 186:5569-5579.
44. Kessel A., Haj T., Peri R., et al. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T regulatory cells. Autoimmun Rev 2012, 11:670-677.
45. Yu S., Maiti P.K., Dyson M., et al. B cell-deficient NOD.H-2h4 mice have CD4+CD25+T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis. J Exp Med 2006, 203:349-358.
46. Sun J.B., Flach C.F., Czerkinsky C., et al. B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit. J Immunol 2008, 181:8278-8287.
47. Singh A., Carson W.F., Secor E.R., et al. Regulatory role of B cells in a murine model of allergic airway disease. J Immunol 2008, 180:7318-7326.
48. Zhang L., Yi H., Xia X.P., et al. Transforming growth factor-β: an important role in CD4(+)CD25(+) regulatory T cells and immune tolerance. Autoimmunity 2006, 39:269-276.
49. Korganow A.S., Ji H., Mangialaio S., et al. From systemic T cell self-reactivity to organ specific autoimmune disease via Ig. Immunity 1999, 10:451-461.
50. Yin Z., Bahtiyar G., Zhang N., et al. IL-10 regulates murine lupus. J Immunol 2002, 169:2148-2155.
51. Kala M., Miravalle A., Vollmer T. Recent insights into the mechanism of action of glatiramer acetate. J Neuroimmunol 2011, 235:9-17.
52. Assier E., Boissier M.C., Dayer J.M. Interleukin-6: from identification of the cytokine to development of targeted treatments. Joint Bone Spine 2010, 77:532-536.
53. Ota S.I., Niiro H., Tsuzuki H., et al. Induction of regulatory B cells in healthy individuals and patients with systemic lupus erythematosus. Arthritis Rheum 2011, 63:1766. [Abstract].
54. Richez C., Blanco P., Rifkin I., et al. Role for toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus. Joint Bone Spine 2011, 78:124-130.
55. Ochoa-Reparaz J., Mielcarz D.W., Haque-Begum S., et al. Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora. Gut Microbes 2010, 1:103-108.
56. Olkhanud P.B., Damdinsuren B., Bodogai M., et al. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+T cells to T regulatory cells. Cancer Res 2011, 71:3505-3515.
57. Fillatreau S. Novel regulatory functions for toll-like receptor-activated B cells during intracellular bacterial infection. Immunol Rev 2011, 240:52-71.
58. Lundy S.K., Boros D.L. FAS-ligand expressing B-1a lymphocytes mediate CD4(+)-T cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10. Infect Immun 2002, 70:812-819.
59. Harn D.A., McDonald J., Atochina O., et al. Modulation of host immune responses by helminth glycans. Immunol Rev 2009, 230:247-257.
60. Hussaarts L., van der Vlugt L.E., Yazdanbakhsh M., et al. Regulatory B cell induction by helminths: implications for allergic disease. J Allergy Clin Immunol 2011, 128:733-739.